Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiovascular late effects.

Dawn Camp-Sorrell1

  • 1Hematology Oncology Associates of Alabama, Sylacauga, Alabama, USA.

Oncology (Williston Park, N.Y.)
|April 25, 2008
PubMed
Summary
This summary is machine-generated.

Cancer survivors treated with cardiotoxic chemotherapy or radiation face higher risks of heart problems. Regular cardiac evaluations are crucial during follow-up to detect potential cardiovascular late effects early.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Venous Access Devices: Clinical Rounds.

Asia-Pacific journal of oncology nursing·2017
Same author

Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2013
Same author

State of the science of oncology vascular access devices.

Seminars in oncology nursing·2010
Same author

Cancer and its treatment effect on young breast cancer survivors.

Seminars in oncology nursing·2009
Same author

Accessing and deaccessing ports: where is the evidence?

Clinical journal of oncology nursing·2009
Same author

Hemolytic uremic syndrome.

Oncology nursing forum·2008
Same journal

Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma.

Oncology (Williston Park, N.Y.)·2026
Same journal

Access to Care and the Affordable Care Act: Why Do Problems Exist 15 Years Later?

Oncology (Williston Park, N.Y.)·2026
Same journal

Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review.

Oncology (Williston Park, N.Y.)·2026
Same journal

Perceived Social Support, Anxiety, and Depression Among Women With Breast Cancer.

Oncology (Williston Park, N.Y.)·2026
Same journal

Before Certainty.

Oncology (Williston Park, N.Y.)·2026
Same journal

Adult T-Cell Leukemia/Lymphoma and Epstein-Barr Virus-Positive DLBCL: A Rare Concomitant Association.

Oncology (Williston Park, N.Y.)·2026
See all related articles

Area of Science:

  • Cardiology
  • Oncology
  • Cancer Survivorship

Background:

  • Cardiotoxic cancer therapies, including chemotherapy and mediastinal radiation, increase long-term cardiovascular risks for survivors.
  • Cardiovascular late effects represent a significant concern in cancer survivorship care.

Purpose of the Study:

  • To highlight the importance of cardiac monitoring in cancer survivors.
  • To outline key factors for evaluating cardiac function in follow-up care.

Main Methods:

  • Review of established guidelines and clinical evidence regarding cardiovascular late effects.
  • Identification of risk factors, symptoms, and treatment modalities associated with cardiac complications.

Main Results:

  • Cancer survivors exposed to cardiotoxic treatments are at elevated risk for cardiovascular complications.

Related Experiment Videos

  • Cardiac evaluation should be tailored based on individual risk factors, symptoms, and treatment history.

    • Conclusions:

    • Proactive cardiac surveillance is essential for managing cardiovascular late effects in cancer survivors.
    • Early detection and management of cardiac symptoms can improve long-term outcomes for cancer survivors.